Recce Pharmaceuticals Ltd. (AU:RCE) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Recce Pharmaceuticals Ltd. (ASX: RCE) has requested a trading halt on its securities as it prepares to make a significant announcement regarding its Phase 3 Diabetic Foot Ulcer Infection Approval. The halt will remain until December 9, 2024, or until the announcement is released, creating anticipation among investors about the company’s future prospects.
For further insights into AU:RCE stock, check out TipRanks’ Stock Analysis page.
